fashion -WSS

fashion

author：Wikipedia 2025-09-28 20:33:20 - browse：47811

Fatty liver foregrounds arteries and veins surrounded by red blood cells — health coverage from STAT — Adobe

As drugmakers race to join the obesity drug market ignited by the approval of Wegovy and Zepbound, they’re not just competing on their drugs’ weight loss effects. They’re also competing on their products’ ability to treat a severe form of liver disease.

A new update of the STAT Obesity Drug Tracker shows that at least 23 — about one-fifth — of the 105 obesity treatments in development or on the market are also being investigated for metabolic dysfunction-associated steatohepatitis, the fatty liver disease known as MASH (and previously called NASH).

In this update, STAT has added a category — “other diseases investigated” — to show conditions beyond obesity for which a compound is being studied. Type 2 diabetes is the most common – it’s long been linked to obesity, and the latest GLP-1 treatments like Wegovy and Zepbound were initially developed as diabetes drugs. But behind diabetes, the next most common disease under investigation for obesity candidates is MASH.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Galapagos to make CAR

explore

WSS

I learned firsthand about improving diversity in clinical trials

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Cherokee Nation medical school graduates its first class

Galapagos to make CAR

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

focus

fashion

knowledge

What does generative AI mean for health care? We asked experts

Awakening the world to the whoosh: A patient's crusade

Jerome Adams on the need for new antivirals for Covid

Divers poised to search for children washed away in Pennsylvania flash flood

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

Wildfire smoke exposes gaps in outdoor worker protections

Divers poised to search for children washed away in Pennsylvania flash flood

George Santos makes 1st court appearance after pleading not guilty to 13 counts

WuXi Biologics beefs up its lobbying operation

hotspot

STAT reporters are Pulitzer Prize finalists for investigative reporting

Free medical tuition alone isn't enough to close gaps in primary care

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Why Congress must ban federal programs from using QALYs

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

HHS suspends federal funding for EcoHealth Alliance

explore

hotspot

entertainment

knowledge